Max Healthcare, Apollo Hospitals shares rally up to 5% as Macquarie double upgrades
Max Healthcare surged nearly 5% in early trade to ₹1,090 on the NSE, leading the Nifty 50 gainers, while Apollo Hospitals gained 4% to hit a fresh 52-week high of ₹9,097
Max Healthcare and Apollo Hospitals shares experienced a notable surge on Friday after global brokerage Macquarie doubled-upgraded both stocks to 'outperform'. This decision was prompted by Macquarie's assessment of improving earnings prospects and a decrease in valuations. Max Healthcare saw its stock price rise by nearly 5% to ₹1,090 on the NSE, becoming the leading stock in the Nifty 50 gainers list. In contrast, Apollo Hospitals shares climbed by 4% to achieve a new 52-week high of ₹9,097.
Macquarie's decision to double-upgrade both companies came after the brokerage stated that consensus earnings have hit their bottom, while valuations have cooled off. The firm believes that the initial impact of the bed expansion cycle on earnings is already reflected in the current stock prices. They also noted that new capacity is expanding at a steady rate.
To further bolster the positive outlook, Macquarie increased its target price for Max Healthcare to ₹1,450 and for Apollo Hospitals to ₹10,500. Macquarie's assessment suggests that Max Healthcare offers a more favorable risk-reward proposition compared to Apollo Hospitals.
Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.